Systems Biology and Proteomics
Dr. Richard Kriwacki, St. Jude Children's Research Hospital
"Intrinsically disordered proteins"
Dr. Brian Baker, University of Notre Dame
Presentation title to be announced
Dr. Stephen Demarest, Biogen Idec
"Mechanism of action studies of anti-insulin-like growth factor antibodies by ITC200 and Biacore to develop a best-in-class biotherapeutic"
Dr. Bilikallahalli Muralidhara, Pfizer
"Unique applications of Isothermal Titration Calorimetry (ITC) in formulation development of biologics"
Dr. Kenneth R. Miller, MedImmune
"Development of Surface Plasmon Resonance (SPR) binding assays for lot release and QC Laboratories"
Dr. Steve Swanson, Amgen
"Use of SPR for immunogenicity assessment of therapeutic proteins"
Small Molecule Drug Discovery
Dr. Ernesto Friere, Johns Hopkins University
"Thermodynamic rules for the optimization of drug candidates"
Dr. Jing Zhou, Novartis Institutes for Biomedical Research
"A combination approach of Biacore and ITC in resolving specific and nonspecific binding of early compounds to target"
Dr. Kirk Wright, Novartis Institutes for Biomedical Research
"Use of label-free biophysical techniques to identify and validate small molecule inhibitors of protein-protein interactions"
Dr. Anthony Reeves, Aberdeen Proving Ground
"Development of stoichiometric and catalytic bioscavenger enzymes and oximes for the treatment of organophosphorus nerve agent poisoning"
Dr. Nand Kishore, Indian Institute of Technology
"Quantitative understanding of bio-molecular interactions: protein folding intermediates and drug-protein interactions"
Dr. David Myszka, University of Utah
"The evolution of biosensor applications"
Dr. Gregg Chenail, Novartis Institutes for Biomedical Research
"The use of Biacore technology in the infectious diseases drug discovery process"
Nucleic Acids and Glycoproteins
Dr. Jinkeng Asong, University of Georgia
"Characterizing the differential innate immune recognition of peptidoglycans by toll-like receptor 2 using surface plasmon resonance technology"